Navigation Links
Biomedtex Inc. Announces Direction of Initial Product Line
Date:10/25/2007

BOCA RATON, Fla., Oct. 25 /PRNewswire-FirstCall/ -- Biomedtex Inc. (Pink Sheets: BMDX.PK) ("Biomed" or "the Company")

Biomedtex is pleased to announce the company's initial direction for its first line of health-conscious products manufactured entirely in the United States. The product line will consist of several high-end specialty lines of flavored and unflavored waters utilizing various pure natural elements, silver being the first, while maintaining a price point consistent with current specialty waters already on the consumer market.

Additionally, successful talks have been continuing with an international award-winning natural spring water company with the focus of using their product as the base water ingredient in the product line. Biomedtex is also aggressively pursuing a potential candidate for a joint venture looking to increase its market share in an accelerated manner.

"I am very excited about the direction of our company to date and looking forward to our positive expansion," said A. Marc Rocca, President COE COB, Biomedtex Inc.

A. Marc Rocca

President COE COB

Biomedtex Inc.

917-526-6700

About Biomedtex Inc.

The Company's mission is to identify, evaluate and assess a broad spectrum of global medical technologies, and healthcare solutions, and then seek to capture and promote innovations with significant commercial and beneficial potential. Biomedtex is a biomedical research company exploring centuries old medical benefits of natural elements. Biomedtex will examine the potential of these benefits by bringing these alternative medical solutions to the mass market through FDA approval.

Safe Harbor Statement: This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward-looking statements, particularly those risks and uncertainties inherent in the process of developing start-up companies. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. Biomedtex Inc. disclaims any intent or obligation to update those forward-looking statements, except as otherwise specifically stated.

http://www.biomedtex.com


'/>"/>
SOURCE Biomedtex Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life ... the development of liquid biopsy tests based on ... into an exclusive license agreement with its first ... proprietary liquid biopsy test for prostate cancer, the ... Korea . This is the first overseas ...
(Date:2/16/2017)... Research and Markets has announced the addition ... to their offering. ... The study scope includes ... chassis organisms, synthetic cells, production systems), enabling technologies (DNA ... specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, agriculture) ...
(Date:2/16/2017)... Mass. , Feb. 16, 2017   Biostage, ... the "Company"), a biotechnology company developing bioengineered organ implants ... esophagus, bronchus and trachea, announced today the closing on ... of 20,000,000 shares of common stock and warrants to ... proceeds of $8.0 million. The offering was priced at ...
(Date:2/16/2017)... 16, 2017 UCHealth ( Aurora, Colorado ... for pulmonary nodule patient management. In addition to optimizing ... spot on the lung, UCHealth looks to improve provider ... entry. Stephanie Brown, RN , Thoracic ... patients with an Excel spreadsheet, which was extremely arduous ...
Breaking Biology Technology:
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market Intelligence ... Biometrics and Digital Identity".  Acuity characterizes 2017 as ... when increased adoption reflects a new understanding of ... "Biometrics and digital identity are often perceived ... Maxine Most , Principal of Acuity Market intelligence. ...
(Date:1/24/2017)... YORK , Jan. 24, 2017 ... study of the laboratory use of nuclear magnetic ... 363 experienced end-users and profiled current practices, developments, ... years, as well as growth and opportunities. These ... Instrument suppliers, NMR instruments, needs and innovation requirements, ...
(Date:1/23/2017)... latest mobile market research from Acuity Market Intelligence reveals ... average price of a biometric smartphone decreased from $849 ... are now 120 sub-$150 models on the market at ... a year ago at an average price of $127. ... Acuity Market Intelligence Principal, "Biometric Smartphones are a global ...
Breaking Biology News(10 mins):